Abstract:Abstract Introduction Glaucoma is a sight-threatening retinal neuropathy associated with elevated intraocular pressure (IOP) due to degeneration and fibrosis of the trabecular meshwork (TM). Glaucoma medications aim to reduce IOP without targeting the specific TM pathology, Bone-marrow mesenchymal stem cells (MSCs) are used today in various clinical studies. Here, we investigated the potential of MSCs therapy in an glaucoma-like ocular hypertension (OHT) model and decipher in vitro the effects of MSCs on primary human trabecular meshwork cells. Methods Ocular hypertension model was performed by cauterization of 3 episcleral veins (EVC) of Long-Evans male rat eyes. MSCs were isolated from rat bone marrow, amplified in vitro and tagged with quantum dot nanocrystals. Animals were distributed as 1) MSCs group receiving 5.10 5 cells/6μl Minimum Essential Medium and 2) MEM group receiving 6μl MEM (n = 10 each). Injections were performed into the anterior chamber of 20 days-hypertensive eyes and IOP was monitored twice a week for 4 weeks. At the end of experiment, cell distribution in the anterior segment was examined in confocal microscopy on flat mounted corneas. Moreover, we tested in vitro effects of MSCs conditioned medium (MSC-CM) on primary human trabecular meshwork cells (hTM cells) using Akt activation, myosin phosphorylation and TGF-β 2 -dependent profibrotic phenotype in hTM cells. Results We demonstrated a rapid and long-lasting in vivo effect of MSCs transplantation that significantly reduced IOP in hypertensive eyes induced by EVC. MSCs were located to the ciliary processes and the TM. Enumeration of RGCs on whole flat-mounted retina highlighted a protective effect of MSCs on RGCs death. In vitro, MSC-CM promotes: (i) hTM cells survival by activating the antiapoptotic pathway, Akt, (ii) hTM cells relaxation as analyzed by the decrease in myosin phosphorylation and (iii) inhibition of TGF-β 2 -dependent profibrotic phenotype acquisition in hTM cells. Conclusions MSCs injection in the ocular anterior chamber in a rat model of OHT provides neuroprotective effect in the glaucoma pathophysiology via TM protection. These results demonstrate that MSCs constitute promising tool for treating ocular hypertension and retinal cell degeneration.

Development of a stem cell tracking platform for ophthalmic applications using ultrasound and photoacoustic imaging

Multimodal Imaging-Guided Stem Cell Ocular Treatment

In Vivo Subretinal ARPE-19 Cell Tracking Using Indocyanine Green Contrast-Enhanced Multimodality Photoacoustic Microscopy, Optical Coherence Tomography, and Fluorescence Imaging for Regenerative Medicine

Multimodal Imaging-Guided Spatiotemporal Tracking of Photosensitive Stem Cells for Breast Cancer Treatment

Integrating a Fundus Camera with High-Frequency Ultrasound for Precise Ocular Lesion Assessment

In Vivo Photoacoustic Monitoring of Stem Cell Location and Apoptosis with Caspase-3-Responsive Nanosensors

Development Of A Percutaneous Optical Imaging System For Tracking Vasclar Gene Expression: An Ultrasound-Guided Ex Vivo Feasibility Study

Multimodal High-Resolution Imaging of Photoreceptor Precursor Cells Using Gold Nanoparticles

Development of A Percutaneous Optical Imaging System for Tracking Vascular Gene Expression: A Feasibility Study Using Human Tissue Like Phantoms

Characterizing differences between MSCs and TM cells: Toward autologous stem cell therapies for the glaucomatous trabecular meshwork

Unveiling the improved targeting migration of mesenchymal stem cells with CXC chemokine receptor 3-modification using intravital NIR-II photoacoustic imaging

Visualizing Micro-anatomical Structures of the Posterior Cornea with Micro-optical Coherence Tomography.

Tracking mesenchymal stromal cells using an ultra-bright TAT-functionalized plasmonic-active nanoplatform

Magnetic Nano-Platform Enhanced Ipsc-Derived Trabecular Meshwork Delivery and Tracking Efficiency

In Vivo Tracking of Individual Stem Cells Labeled with Nanowire Lasers Using Multimodality Imaging.

Real-time OCT Guidance and Multimodal Imaging Monitoring of Subretinal Injection Induced Choroidal Neovascularization in Rabbit Eyes

Stem Cell Tracking with Optically Active Nanoparticles.

High-frequency ultrasound point-of-care device to quantify myopia-induced microstructural changes in the anterior sclera

CT/NIRF dual-modal imaging tracking and therapeutic efficacy of transplanted mesenchymal stem cells labeled with Au nanoparticles in silica-induced pulmonary fibrosis

Non-invasive imaging of cell-based therapies using acoustic reporter genes

Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma